A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes

Area of Science:

• Biochemistry
• Microbiology
• Dermatology

Background:

• Propionibacterium acnes is a key factor in acne vulgaris pathogenesis.
• Antibiotic resistance in P. acnes and other bacteria like Staphylococcus epidermidis is a growing clinical concern.
• Conventional antibiotics face limitations due to resistance development.

Purpose of the Study:

• To evaluate the efficacy of a polycation antimicrobial peptide (AMP) mimic, C12-50, against Propionibacterium acnes.
• To assess the potential for resistance development to C12-50 in P. acnes.
• To compare the resistance profile of C12-50 with a conventional antibiotic, erythromycin.

Main Methods:

• Minimum Inhibitory Concentration (MIC) determination of C12-50 against P. acnes (ATCC 6919).
• Serial passage studies over ten passages to monitor resistance development to C12-50.
• Parallel studies using erythromycin to confirm known resistance patterns.

Main Results:

• C12-50 demonstrated potent activity against P. acnes with an MIC of 6.3 µg mL⁻¹.
• No significant increase in MIC was observed after ten serial passages, indicating no resistance buildup.
• Erythromycin treatment resulted in the expected resistance buildup, confirming the study's methodology.

Conclusions:

• Polycation AMP mimics like C12-50 represent a viable therapeutic strategy against P. acnes.
• C12-50 shows a favorable resistance profile compared to conventional antibiotics.
• Further research into polycation AMP mimics could lead to novel treatments for acne vulgaris.